Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
                
Learn More
Learn More
                                    NFATC1/NFAT2 Antibody, Novus Biologicals™
                                    
                                    
                                    
                                    
                                
                            
                            
                            
                            
Rabbit Polyclonal Antibody has been used in 1 publication
Supplier: Novus Biologicals NBP25773925UL
Description
NFATC1/NFAT2 Polyclonal specifically detects NFATC1/NFAT2 in Human, Mouse samples. It is validated for Immunocytochemistry/Immunofluorescence.Specifications
| NFATC1/NFAT2 | |
| Polyclonal | |
| Immunocytochemistry/Immunofluorescence 0.25-2 μg/mL | |
| MGC138448, NFAT transcription complex cytosolic component, NFAT2cytoplasmic 1, NFATC, NF-ATC, NFATc1, NF-ATc1, nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 | |
| Rabbit | |
| Affinity Purified | |
| RUO | |
| Primary | |
| Specificity of antibody verified on a Protein Array containing target protein plus 383 other non-specific proteins. | |
| Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. | 
| Immunocytochemistry, Immunofluorescence | |
| Unconjugated | |
| PBS (pH 7.2), 40% Glycerol with 0.02% Sodium Azide | |
| NFATC1 | |
| This antibody was developed against a recombinant protein corresponding to the following amino acid sequence:GYGAALDGGPAGYFLSSGHTRPDGAPALESPRIEITSCLGLYHNNNQFFHDVEVEDVLPSSKRSPSTATLSLPSLEAYRD | |
| 25 μL | |
| Wnt Signaling Pathway | |
| 4772 | |
| Human | |
| IgG | 
                    Product Content Correction
                
                Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
			
            For Research Use Only
Spot an opportunity for improvement?Share a Content Correction